Algorae Pharmaceuticals Limited
1AI
Rank in Stocks
#31361
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Share Price
$0.00634756
Last synced: 2026-10-16
Market Cap
$12.87M
Change (1 day)
0.00%
Change (1 year)
-37.64%
Country
AU
Trade Algorae Pharmaceuticals Limited (1AI)
Category
Healthcare
Market Capitalization of Algorae Pharmaceuticals Limited(1AI)
Market Cap: $12.87M
As of October 2026 Algorae Pharmaceuticals Limited has a market cap of $12.87M. This makes Algorae Pharmaceuticals Limited the world's 31361st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Algorae Pharmaceuticals Limited from 2004 to 2026
1AI compared with Top 5 Most Popular stocks
